Categories

News

Shared Purpose: Gore’s 2022 Enterprise New Sustainability Update

Posted July 11, 2023

In this 2022 Enterprise Sustainability Update our sustainability efforts — across purposeful innovation, environmental stewardship, and enhancing our social impact — stay true to our core values and uphold our brand promise: Together, improving life.

Event

Join W. L. Gore & Associates for the Live + Virtual Bioprocessing Summit Europe

March 19, 2024 - March 21, 2024

Join W. L. Gore & Associates at BioProcessing Summit Europe, Europe’s Premier Conference to Optimize Your Bioprocesses.

Event

Unpacking the Resin Alternatives: Single-Use Protein a Tech That Can Reduce Costs and Accelerate Your Clinical Journey

March 14, 2024

Explore exclusive research and analysis on the future of protein A purification, the potential of single-use protein A membrane capture devices and the opportunities they offer over costly resin columns during antibody drug development.

Event

Visit GORE at BioProcess International in San Diego

March 11, 2024 - March 14, 2024

Join W. L. Gore & Associates for BioProcess International, the largest BioProcessing event for learning how to accelerate promising biologics, cell & gene therapies towards commercial success.

Event

Visit GORE at BioProcess International in Boston

September 19, 2023 - September 21, 2023

Join W. L. Gore & Associates for BioProcess International, the largest BioProcessing event for learning how to accelerate promising biologics, cell & gene therapies towards commercial success.

Event

Visit GORE at BioProcessing Summit in Boston

August 14, 2023 - August 17, 2023

As one of the event sponsors, Gore invites you to join us at the Boston Sheraton, Booth # 306 — or join us online.

Event

Visit Gore at TIDES USA 2023

May 7, 2023 - May 10, 2023

Gore is exhibiting at this year’s TIDES USA Conference, and you’re invited to visit our booth, where we’ll be demonstrating the benefits of GORE® LYOGUARD® Freeze-Drying Trays. Chat with Gore representatives and see how our freeze-drying trays protect both pharmaceutical products and operator safety.

Press Release

GORE PHARMBIO INTRODUCES 250ML, 500ML AND 1L PROTEIN CAPTURE DEVICES WITH PROTEIN A TO DELIVER CONSISTENT SCALABILITY AND INCREASED PRODUCTIVITY ACROSS SIZES

Posted April 11, 2023

W. L. Gore & Associates, Inc. (“Gore”), a global materials science company, continues to build on its growing portfolio of protein capture devices with the introduction of its 250mL, 500mL and 1L GORE® Protein Capture Devices with Protein A. The offerings follow commer-cial availability of its 116mL and 232mL sizes introduced in mid 2022.

Event

Join W. L. Gore & Associates for the Live + Virtual Bioprocessing Summit Europe

March 14, 2023 - March 16, 2023

Join W. L. Gore & Associates at BioProcessing Summit Europe, Europe’s Premier Conference to Optimize Your Bioprocesses

Event

Visit Gore at TIDES ASIA 2023

March 7, 2023 - March 9, 2023

Gore is exhibiting at this year’s TIDES Asia Conference, and you’re invited to visit our stand, where we’ll be demonstrating the benefits of GORE® LYOGUARD® Freeze-Drying Trays. Chat with Gore representatives and see how our freeze-drying trays protect both pharmaceutical products and operator safety.

Event

Visit GORE at BioProcess International in San Diego

February 27, 2023 - March 2, 2023

Join W. L. Gore & Associates for BioProcess International, the largest BioProcessing event for learning how to accelerate promising biologics, cell & gene therapies towards commercial success.

Press Release

AGC Biologics and Gore Collaborate on New Protein A-based Purification Technology and Contract Manufacturing Services for Antibody Therapies

Posted December 12, 2022

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a collaboration with W.L. Gore & Associates (Gore) that features Protein A affinity purification technology from Gore alongside the global CDMO’s contract development and manufacturing services. By using GORE and AGC Biologics, biopharmaceutical companies can improve downstream purification processes, eliminate column bioburden issues, increase product material yields in the research and development (R&D) stages, and help lower costs for clinical manufacturing.

News

Propelling Your Downstream Purification

Posted December 7, 2022

WL Gore and AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), recently announced a powerful collaboration. The partnership brings the GORE® Protein Capture Devices with Protein A as an integral component in the AGC Biologics’ mAb-based CDMO services. The combined offering from GORE and AGC Biologics is available across the CDMO’s global network.

Load more news